Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.360
+0.060 (2.61%)
At close: Sep 12, 2025, 4:00 PM EDT
2.390
+0.030 (1.27%)
Pre-market: Sep 15, 2025, 4:42 AM EDT
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of $21.18 million as of September 15, 2025. Its market cap has increased by 61.71% in one year.
Market Cap
21.18M
Enterprise Value
25.53M
1-Year Change
61.71%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since March 31, 2015, Aytu BioPharma's market cap has increased from $200.00K to $21.18M, an increase of 10,492.05%. That is a compound annual growth rate of 56.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 14.60M | 39.05% |
| Dec 31, 2024 | 10.50M | -33.54% |
| Dec 29, 2023 | 15.80M | 33.90% |
| Dec 30, 2022 | 11.80M | -68.95% |
| Dec 31, 2021 | 38.00M | -50.33% |
| Dec 31, 2020 | 76.50M | 278.71% |
| Dec 31, 2019 | 20.20M | 197.06% |
| Dec 31, 2018 | 6.80M | -30.61% |
| Dec 29, 2017 | 9.80M | 9,700.00% |
| Dec 30, 2016 | 100.00K | -66.67% |
| Dec 31, 2015 | 300.00K | 50.00% |
| Mar 31, 2015 | 200.00K | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |